Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The All-Russian Institute of Medicinal and Aromatic Plants (VILAR) is a premier federal research institution in Russia dedicated to the development of plant-derived pharmaceuticals. Founded in 1931, the institute oversees the entire drug development process, from the cultivation of medicinal plants and phytochemical research to industrial-scale manufacturing. VILAR's portfolio includes several well-established herbal medicines such as the antiarrhythmic Allapinin and the antiviral Hyporamin. The institute also maintains a significant botanical garden and a unique gene bank of medicinal plant resources to support its R&D activities. By integrating agricultural science with modern pharmacology, VILAR remains a central figure in the Russian phytopharmaceutical industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on All-Russian Institute of Medicinal and Aromatic Plants.